<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150905023897N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-16</date_registration>
      <primary_sponsor>Tarbiat Modares University</primary_sponsor>
      <public_title>Investigating the effect of midwifery-designed training on perceived anxiety and pain intensity from hysterosalpingography in infertile women</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of midwifery-designed training on perceived anxiety and pain intensity from hysterosalpingography in infertile women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-05-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>86</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68926</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Single, Purpose: Education/Guidance, Other design features: In this research, it should be measured the level of target group's knowledge about hysterosalpingography. To achieve this, a questionnaire should be prepare by researcher whose validity and reliability are also measured, Randomization description: In order to perform randomization, the researcher put 4 balls, including 2 white balls: intervention and control, and 2 black balls: even day and odd day, which he named in this way and put them in a container and asked someone to pick up two different colors. This is the way that those balls were selected: even day and intervention, odd day and control. In this way, people who visit on even days are in the intervention group, and people who visit on odd days are in the control group, Blinding description: After admission, people are randomly assigned to each of the intervention and control groups.
None of them were informed about their group and they just trained about the stages what should they do.</study_design>
      <phase>2</phase>
      <hc_freetext>Female infertility.</hc_freetext>
      <i_freetext>Intervention 1: Control group: Control group: After accepting people according to the entry criteria, and obtaining informed consent, people are randomly assigned to the control and intervention groups. The control group does not receive any educational or counseling intervention and only the center's routine admission is done for them. The other mentioned cases are the same in both groups. including questionnaires and timings necessary to measure the variables. Intervention 2: Intervention group: After accepting people according to the entry criteria, and obtaining informed consent, people are randomly assigned to control and intervention groups. People in the intervention group receive educational items and counseling (educational intervention) before performing hysterosalpingography.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information on the main outcome of the study

When:
2023

To whom:
Academic researchers

Conditions:
Use for additional research in the future

Where to obtain:
Email Addressing Responsible for study

How to obtain:
Submit a request to study and follow up

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shahideh Jahanian Sadatmahalleh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Jalal  E Al Ahmad</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>141173116</zip>
        <telephone>+98 21 8288 4826</telephone>
        <email>shahideh.jahanian@modares.ac.ir</email>
        <affiliation>Tarbiat Modares University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shahideh Jahanian Sadatmahalleh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Jalal E Al Ahmad</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۱۱۷۱۳۱۱۶</zip>
        <telephone>+98 21 2230 6480</telephone>
        <email>shahideh.jahanian@modares.ac.ir</email>
        <affiliation>Tarbaiat Modares University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Voluntary infertile women
Age 20-49 years
Iranian nationality
Ability to speak Persian
Literacy
Not suffering from known anxiety disorders or other mental illnesses affecting anxiety under treatment
No history of HSG
People who are inclined to participate in the study.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>49 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Patient withdrawal from the study
Failure to complete the HSG process for any reason
Presence of tubal or uterine lesions, such as cervical stenosis, which cause "severe pain" in the HSG process</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N97.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Female infertility of tubal origin</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: Control group: After accepting people according to the entry criteria, and obtaining informed consent, people are randomly assigned to the control and intervention groups. The control group does not receive any educational or counseling intervention and only the center's routine admission is done for them. The other mentioned cases are the same in both groups. including questionnaires and timings necessary to measure the variables.</i_keyword>
      <i_keyword>Intervention group: After accepting people according to the entry criteria, and obtaining informed consent, people are randomly assigned to control and intervention groups. People in the intervention group receive educational items and counseling (educational intervention) before performing hysterosalpingography.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The patient's heart rate. Timepoint: Heart rate measurement at the beginning of the study (before the intervention), half an hour before the intervention, immediately and half an hour after the intervention. Method of measurement: Pulse meter.</prim_outcome>
      <prim_outcome>The patient's blood pressure. Timepoint: Blood pressure measurement at the beginning of the study (before the intervention), half an hour before the intervention, immediately and half an hour after the intervention. Method of measurement: Sphygmomanometer.</prim_outcome>
      <prim_outcome>Patients' awareness of hysterosalpingography. Timepoint: Measuring the patient's knowledge about hysterosalpingography at the beginning of the study (before the intervention), half an hour before the intervention, immediately and half an hour after the intervention. Method of measurement: Hysterosalpingography awareness questionnaire (made by a researcher).</prim_outcome>
      <prim_outcome>Patient anxiety. Timepoint: Measuring the patient's anxiety at the beginning of the study (before the intervention), half an hour before the intervention, immediately and half an hour after the intervention. Method of measurement: State Trait Anxiety Inventory (STAI).</prim_outcome>
      <prim_outcome>Perceived pain from the hysterosalpingography procedure. Timepoint: Measurement of perceived pain in the initial study (before the intervention), half an hour before the intervention, treatment and half an hour after the intervention. Method of measurement: Visual analog scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tarbiat Modares University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-10-03</approval_date>
        <contact_name>Ethics committee of Tarbiat Modares University</contact_name>
        <contact_address>Tarbiat Modares University,  Nasr bridg, Ale ahmad high way,Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
